Ted D. Kellner - Apr 21, 2025 Form 4 Insider Report for AIM ImmunoTech Inc. (AIM)

Role
Director
Signature
/s/ Ted D Kellner
Stock symbol
AIM
Transactions as of
Apr 21, 2025
Transactions value $
$50,000
Form type
4
Date filed
4/23/2025, 04:35 PM
Previous filing
Dec 23, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AIM Common Stock Purchase $50K +1.97M +196850.4% $0.03 1.97M Apr 11, 2025 Direct F1
holding AIM Common Stock 1.46M Apr 21, 2025 By Kelvest I LP F2, F5
holding AIM Common Stock 270K Apr 21, 2025 By Beta Fund Investment Club F3
holding AIM Common Stock 25K Apr 21, 2025 By Kellner, Ted Combined Profit Sharing/Money Purchase Plan F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased pursuant to a purchase agreement executed on April 11, 2025, but first required approval from the NYSE American which was received on April 21, 2025.
F2 Shares held by Kelvest I LP, for which the reporting person serves as Manager of T&M Partners LLC, General Partner of Kelvest I LP.
F3 Shares held by the Beta Fund Investment Club, for which the reporting person serves as the manager and is an investor. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
F4 Shares held by the Kellner, Ted Combined Profit Sharing/Money Purchase Plan, for which the reporting person serves as trustee.
F5 Amends prior Form 3 filed by the reporting person with the SEC on 12/23/2024 due to a restructuring of family entities effective April 1, 2025. The reporting person is beneficial owner due to his role as Manager of T&M Partners LLC which serves as General Partner of a newly formed pooled investment vehicle that controls shares of the Company not previously reported on Form 3."